<DOC>
	<DOCNO>NCT02065297</DOCNO>
	<brief_summary>The aim open , control , multicentre biomedical research study identify new marker specifically associate Horton 's disease . This would make possible improve diagnosis management disease . Participation consist take one several blood sample depend group patients/controls .</brief_summary>
	<brief_title>Quantitative Functional Study TH17 Lymphocytes Horton 's Disease ( HD )</brief_title>
	<detailed_description />
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Infection</mesh_term>
	<mesh_term>Giant Cell Arteritis</mesh_term>
	<mesh_term>Polymyalgia Rheumatica</mesh_term>
	<criteria>Patients Patients provide write informed consent Patients national health insurance cover Age : 50 90 year Patients Horton ' disease : diagnosis , treatment remission relapse Patients infectious disease : Bacteriologically radiologically confirm Presenting inflammatory syndrome define : CRP ≥ 10 mg / L Fibrinogen ≥ 4 g / L ESR ≥ 30 mm H1 Patients neoplasia ( solid tumour hemopathy ) : At diagnosis , treatment chemotherapy Presenting inflammatory syndrome define : CRP ≥ 10 mg / L Fibrinogen ≥ 4 g / L ESR ≥ 30 mm H1 Controls : These healthy volunteer recruit among blood donators Dijon CHU , voluntary hospital personnel ( nurse , doctor secretary ) , patient EPHAD ( Champmaillot centre geriatric patient ) patient without infectious , inflammatory , autoimmune disease ( CRP &lt; 5mg / L ) cancer recruit investigate department Dijon CHU . They match age sex . Age : 18 90 year Patients national health insurance cover provide write informed consent Absence inflammatory syndrome ( CRP &lt; 5 mg / L ) Exclusion Criteria : Any patient meet inclusion criterion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>90 Years</maximum_age>
	<verification_date>July 2013</verification_date>
</DOC>